Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives



Rating:

Share or cite this content

Citations should be made in the following way:
Melissa McDonnell (Galway, Ireland), Melissa McDonnell, Thomas Fardon, Robert Rutherford, James Chalmers. Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis. Eur Respir J 2015; 46: Suppl. 59, 467

Member's Comments

No comment yet.

Related content which might interest you: Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Impact of bronchiectasis on the course of COPD Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Prevalence of hiatus hernia in non-cystic fibrosis bronchiectasis and associations with disease severity Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Predicting hospital admissions in non-CF bronchiectasis using COPD specific severity tools Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Obesity and impairments in chronic obstruction pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019 Prevalence of COPD in vascular diseases Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Presence of aspiration pneumonia is independently associated with mortality, after adjusting for age, disease severity, and comorbities Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015